Skip to main content

Recombinant Human Caspase-8 Protein, CF

R&D Systems, part of Bio-Techne | Catalog # 705-C8/CF

R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
705-C8-010/CF

Key Product Details

Source

E. coli

Accession #

Conjugate

Unconjugated

Applications

Enzyme Activity

Product Specifications

Source

E. coli-derived human Caspase-8 protein
Ser217-Asp384 (Asp285His) (p18 subunit) & Leu385-Asp479 (p10 subunit), with a C-terminal 6-His tag

Purity

>95%, by SDS-PAGE under reducing conditions and visualized by silver stain.

Endotoxin Level

<1.0 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Ser217 (p18 subunit) & Leu385 (p10 subunit)

Predicted Molecular Mass

18 kDa & 10 kDa

SDS-PAGE

18 kDa and 10 kDa, reducing conditions

Activity

Measured by its ability to cleave a fluorogenic peptide substrate Ac-IETD-AFC.
The specific activity is >1,000 pmol/min/μg, as measured under the described conditions.

Formulation, Preparation and Storage

705-C8/CF
Formulation Supplied as a 0.2 μm filtered solution in HEPES, NaCl, DTT and Sucrose.
Shipping The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 6 months from date of receipt, -70 °C as supplied.
  • 3 months, -70 °C under sterile conditions after opening.

Background: Caspase-8

Caspase-8 (Cysteine-aspartic acid protease 8/Casp8a; also named MCH5, FLICA and MACH alpha1) is a 28 kDa member of the peptidase C14A family of enzymes (1, 2, 3). It is widely expressed and is considered an initiating caspase for the apoptotic cascade (4). Caspase-8 acts on a wide variety of substrates, including procaspases‑3, 4, 6, 7, 9 and 10, c‑FLIPL and procaspase-8 itself (1, 5  6). Human procaspase‑8a is a 54‑56 kDa, 479 amino acid (aa) protein (4, 7, 8, 9). It contains two N‑terminal death domains (aa 1‑177), followed by a catalytic site that utilizes His317Gly318 plus Cys360. Normally, it is an inactive, cytosolic monomer (1, 10, 11). But following death‑domain (DD) containing receptor oligomerization, Caspase‑8 is recruited to the death-inducing signaling complex (DISC) that forms around the death domains of the oligomerized receptor (12). FADD/CAP-1 is recruited first, followed by procaspase‑8/CAP‑4 and, possibly, c‑FLIPL and procaspase‑10 (12). The recruitment, or concentration, of procaspase-8 induces homodimerization. This act alone is sufficient for activation. However, the activity level is modest at best, and appears to be directed towards either itself, or c‑FLIPL, which is known to form a functional heterodimer with procaspase‑8 (5, 11). When directed towards itself, autocleavage occurs first between Asp374Ser375, generating a 43 kDa (p43) N‑terminal (aa 1‑374) and an 11 kDa C‑terminal (aa 375‑479) fragment. The C‑terminus is further cleaved between Asp384Leu385 to generate a mature p10 subunit (aa 385‑479). The p43 subunit is next cleaved twice, once between Asp216Ser217, and again between Asp210Ser211 to generate a 26 kDa DD‑containing prodomain (aa 1‑210) with an additional 18 kDa mature p18 subunit (aa 217‑374) (12). p18 and p10 noncovalently associate to form a 28 kDa heterodimer, which subsequently associates with another p18:p10 heterodimer to form an active, mature caspase‑8 molecule. This leaves the DISC to act on downstream apoptotic procaspases. In the event procaspase‑8 comes to the DISC complexed with c-FLIPL, c-FLIPL will be cleaved by procaspase‑8, generating a p43 fragment that is analogous to the Caspase‑8 p43 subunit. This fragment, however, appears not to be an intermediate in a proteolytic cascade. Rather, it serves as a functional subunit, interacting with TRAF2 and activating NF kappaB. This may account for many of the nonapoptotic activities associated with Caspase‑8 (5, 6, 13). Mature human and mouse Caspase‑8a heterodimers are 73% aa identical (14).

References

  1. Chowdhury, I. et al. (2008) Comp. Biochem. Physiol. B 151:10.

  2. Boatright, K.M. & G.S. Salvesen (2003) Curr. Opin. Cell Biol. 15:725.

  3. Launay, S. et al. (2005) Oncogene 24:5137.

  4. Srinivasula, S.M. et al. (1996) Proc. Natl. Acad. Sci. USA 93:14486.

  5. Hughes, M.A. et al. (2009) Mol. Cell 35:265.

  6. Lamkanfi, M. et al. (2007) Cell Death Differ. 14:44.

  7. Fernandes-Alnemri, T. et al. (1996) Proc. Natl. Acad. Sci. USA 93:7464.

  8. Boldin, M.P. et al. (1996) Cell 85:803.

  9. Muzio, M. et al. (1996) Cell 85:817.

  10. Donepudi, M. et al. (2003) Mol. Cell 11:543.

  11. Boatright, K.M. et al. (2003) Mol. Cell 11:529.

  12. Golks, A. et al. (2006) Cell Death Differ. 13:489.

  13. Scaffidi, C. et al. (1997) J. Biol. Chem. 272:26953.

  14. Sakamaki, K. et al. (1998) Eur. J. Biochem. 253:399.

Alternate Names

CASP8, Caspase8, Mch5

Entrez Gene IDs

841 (Human); 12370 (Mouse)

Gene Symbol

CASP8

UniProt

Additional Caspase-8 Products

Product Documents for Recombinant Human Caspase-8 Protein, CF

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Recombinant Human Caspase-8 Protein, CF

For research use only

Loading...
Loading...
Loading...